Pharmacokinetics and biotransformation of tea polyphenols

Current Drug Metabolism

Volumn 15, Issue 1, 2014, Pages 30-36

  Qiao, Jinping ^a   Kong, Xiangyi ^b   Kong, Aiying ^c   Han, Mei ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SICHUAN UNIVERSITY   (China)

^c Institute for Drug and Instrument Control of PLA   (China)

Author keywords

Biotransformation; Metabolite; Pharmacokinetics; Tea polyphenols

Indexed keywords

CATECHIN; CYSTEINE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; GLUTATHIONE; POLYPHENOL DERIVATIVE; THEAFLAVIN; THEARUBIGIN; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; BIOTRANSFORMATION; CAMELLIA SINENSIS; CHEMICAL COMPOSITION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; FIRST PASS EFFECT; GLUCOSIDATION; GLUCURONIDATION; HUMAN; MAXIMUM PLASMA CONCENTRATION; METHYLATION; NONHUMAN; PHARMACOKINETICS; PLASMA CONCENTRATION-TIME CURVE; REVIEW; SULFATION; TEA; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIOTRANSFORMATION; CAMELLIA SINENSIS; HUMANS; POLYPHENOLS;

EID: 84896363848     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200214666131229111336     Document Type: Review

References (81)

1. Chen, H.; Qu, Z.; Fu, L.; Dong, P.; Zhang, X. Physicochemical properties and antioxidant capacity of 3 polysaccharides from green tea, oolong tea, and blacktea. J. Food Sci., 2009, 74, 469-474.
2. Oba, S.; Nagata, C,; Nakamura, K.; Fujii, K.; Kawachi, T.; Takatsuka, N.; Shimizu, H.; Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br. J. Nutr., 2010, 103, 453-459.
3. Chacko, S.M.; Thambi, P.T.; Kuttan, R.; Nishigaki, I. Beneficial effects of green tea: a literature review. Chin. Med., 2010, 5, 13.
4. Yang, C.S.; Wang, X.; Lu, G.; Picinich, S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 2009, 9, 429-439.
5. Cooper, R.; Morre, D. J.; Morre, D. M. Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J. Altern. Complement. Med., 2005, 11, 521-528.
6. Kobayashi, H.; Tanaka, Y.; Asagiri, K.; Asakawa, T.; Tanikawa, K.; Kage, M.; Yagi, M. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine, 2010, 17, 197-202.
7. Cooper, R. Green tea and theanine: health benefits. Int. J. Food Sci. Nutr., 2012, 63S,90-97.
8. Grove, K.A.; Lambert, J.D. Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J. Nutr., 2010, 140, 446-453.
9. Naito, Y.; Yoshikawa, T. Green tea and heart health. J. Cardiovasc. Pharmacol., 2009, 54, 385-390.
10. Wang, Y.; Zhao, Y.; Andrae-Marobela, K.; Okatch, H.; Xiao, J. Tea polysaccharides as food antioxidants: an old woman's tale? Food Chem., 2013, 138, 1923-1927.
11. Khan, N.; Mukhtar, H. Tea polyphenols for health promotion. Life Sci., 2007, 81, 519-533.
12. Xiao, J.; Huo, J.; Jiang, H.; Yang, F. Chemical compositions and bioactivities of crude polysaccharides from tea leaves beyond their useful date. Int. J. Biol. Macromol., 2011, 49, 1143-1151.
13. Li, S.; Lo, C.Y.; Pan, M.H.; Lai, C.S.; Ho, C.T. Black tea: chemical analysis and stability. Food Funct., 2013, 4, 10-18.
14. Kuhnert, N.; Clifford, M.N.; Müller, A. Oxidative cascade reactions yielding polyhydroxy-theaflavins and theacitrins in the formation of black tea thearubigins: evidence by tandem LC-MS. Food Funct., 2010, 1, 180-199.
15. Del Rio, D.; Stewart, A.J.; Mullen, W.; Burns, J.; Lean, M.E.; Brighenti, F.; Crozier, A. HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. J. Agric. Food Chem., 2004, 52, 2807-2815.
16. Smith, T.J. Green Tea Polyphenols in drug discovery - a success or failure? Expert. Opin. Drug Discov., 2011, 6, 589-595.
17. Sang, S.; Lambert, J.D.; Ho, C.T.; Yang, C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res., 2011, 64, 87-99.
18. Feng, WY. Metabolism of green tea catechins: an overview. Curr. Drug Metab., 2006, 7, 755-809.
19. Chen, L.; Lee, M.J.; Li, H.; Yang, C.S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab, Dispos., 1997, 25, 1045-1050.
20. Park, A.M.; Dong, Z. Signal transduction pathways: targets for green and black tea polyphenols. J. Biochem. Mol. Biol., 2003, 36, 66-77.
21. Dimpfel, W.; Kler, A.; Kriesl, E.; Lehnfeld, R. Theogallin and Ltheanine as active ingredients in decaffeinated green tea extract: II. Characterization in the freely moving rat by means of quantitative field potential analysis. J. Pharm. Pharmacol., 2007, 59, 1397-1403.
22. Drynan, J.W.; Clifford, M.N.; Obuchowicz, J.; Kuhnert, N. The chemistry of low molecular weight black tea polyphenols. Nat. Prod. Rep., 2010, 27, 417-462.
23. Menet, M.C.; Sang, S.; Yang, C.S.; Ho, C.T.; Rosen, R.T. Analysis of theaflavins and thearubigins from black tea extract by MALDITOF mass spectrometry. J. Agric. Food Chem., 2004, 52, 2455-2461.
24. Sang, S.; Tian, S.; Stark, R.E.; Yang, C.S.; HO, C.T. New dibenzotropolone derivatives characterized from black tea using LC/MS/MS. Bioorg. Med. Chem., 2004, 12, 3009-3017.
25. Mulder, T.P.; Van Platerink, C.J.; Wijnand Schuyl, P.J.; Van Amelsvoort, J.M. Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl., 2001, 760, 271-279.
26. Chen, H.; Shurlknight, K.; Leung, T.; Sang, S. Structural identification of theaflavin trigallate and tetragallate from black tea using liquid chromatography/electrospray ionization tandem mass spectrometry. J. Agric. Food Chem., 2012, 60, 10850-10857.
27. Ow, Y.Y.; Stupans, I. Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Curr. Drug Metab., 2003, 4, 241-248.
28. Zhu, M.; Chen, Y.; Li, R.C. Pharmacokinetics and system linearity of tea catechins in rat. Xenobiotica, 2001, 31, 51-60.
29. Chow, H.H.; Cai, Y.; Hakim, I.A.; Crowell, J.A.; Shahi, F.; Brooks, C.A.; Dorr, R.T.; Hara, Y.; Alberts, D.S. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res., 2003, 9, 3312-3319.
30. Fu, T; Liang, J.; Han, G.; Lv, L.; Li, N. Simultaneous determination of the major active components of tea polyphenols in rat plasma by a simple and specific HPLC assay. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci., 2008, 875, 363-367.
31. Renouf, M.; Redeuil, K.; Longet, K.; Marmet, C.; Dionisi, F.; Kussmann, M.; Williamson, G.; Nagy, K. Plasma pharmacokinetics of catechin metabolite 4'-O-Me-EGC in healthy humans. Eur. J. Nutr., 2011, 50, 575-580.
32. El-Hady, D.A.; El-Maali, N.A. Determination of catechin isomers in human plasma subsequent to green tea ingestion using chiral capillary electrophoresis with a high-sensitivity cell. Talanta., 2008, 76, 138-145.
33. Wu, L.; Zhang, Q.L.; Zhang, X.Y.; Lv, C.; Li, J.; Yuan, Y.; Yin, F.X. Pharmacokinetics and blood-brain barrier penetration of (+)- catechin and (-)-epicatechin in rats by microdialysis sampling coupled to high-performance liquid chromatography with chemiluminescence detection. J. Agric. Food Chem., 2012, 60, 9377-9783.
34. Lin, L.C.; Wang, M.N.; Tseng, T.Y.; Sung, J.S.; Tsai, T.H. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J. Agric. Food Chem., 2007, 55, 1517-1524.
35. Ullmann, U.; Haller, J.; Decourt, J.P., Girault, N.; Girault, J.; Richard-Caudron, A.S.; Pineau, B.; Weber, P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res., 2003, 31, 88-101.
36. Chow, H. H.; Cai, Y.; Alberts, D. S.; Hakim, I.; Dorr, R.; Shahi, F.; Crowell, J. A.; Yang, C. S.; Hara, Y. Phase I Pharmacokinetic Study of Tea Polyphenols following Single-dose Administration of Epigallocatechin Gallate and Polyphenon E. Cancer Epidemiol. Biomark Prev., 2001, 10, 53-58.
37. Smith, A.J.; Kavuru, P.; Arora, K.K.; Kesani, S.; Tan, J.; Zaworotko, M.J.; Shytle, R.D. Crystal Engineering of Green Tea Epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats. Mol. Pharm., 2013, 10, 2948-2961.
38. Misaka, S.; Kawabe, K.; Onoue, S.; Werba, J.P.; Giroli, M.; Kimura, J.; Watanabe, H.; Yamada, S. Development of rapid and simultaneous quantitative method for green tea catechins on the bioanalytical study using UPLC/ESI-MS. Biomed. Chromatogr., 2013, 27, 1-6.
39. Harada, M.; Kan, Y.; Naoki, H.; Fukui, Y.; Kageyama, N.; Kiso, W. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci. Biotechnol. Biochem., 1999, 63, 973-977.
40. Mata-Bilbao, Mde.L.; Andres-Lacueva, C.; Roura, E.; Jauregui, O.; Escribano, E.; Torre, C.; Lamuela-Raventos, R.M. Absorption and pharmacokinetics of green tea catechins in beagles. Br. J. Nutr., 2008, 100, 496-502.
41. Li, C.; Meng, X.; Winnik, B.; Lee, M.J.; Lu, H.; Sheng, S.; Buckley, B.; Yang, C.S. Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem. Res. Toxicol., 2001, 14, 702-707.
42. Li, C.; Lee, M.J.; Sheng, S.; Meng, X.; Prabhu, S.; Winnik, B.;Huang, B.; Chung, J.Y.; Yan, S.; Ho, C.T.; Yang, C.S. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol., 2000, 13, 177-184.
43. Roura, E.; Andres-Lacueva, C.; Jauregui, O.; Badia, E.; Estruch, R.; Izquierdo-Pulido, M.; Lamuela-Raventos, R. M. Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma (-)-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J. Agric. Food Chem., 2005, 53, 6190-6194.
44. Natsume, M.; Osakabe, N.; Oyama, M.; Sasaki, M.; Baba, S.; Nakamura, Y.; Osawa, T.; Terao, J. Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: Differences between human and rat. Free Radic. Biol. Med., 2003, 34, 840-849.
45. Lee, M.J.; Maliakal, P.; Chen, L.; Meng, X.; Bondoc, F.Y.; Prabhu, S.; Lambert, G.; Mohr, S.; Yang, C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3- gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 1025-1032.
46. Chen, Y.A.; Hsu, K.Y. Pharmacokinetics of (-)-epicatechin in rabbits. Arch. Pharm. Res., 2009, 32, 149-154.
47. Meng, X.; Lee, M.J.; Li, C.; Sheng, S.; Zhu, N.; Sang, S.; Ho, C.T.; Yang, C.S. Formation and identification of 4'-O-Methyl-(-)- epigallocatechin in humans. Drug Metab. Disp., 2001, 29, 789-793.
48. Meng, X.; Sang, S.; Zhu, N.; Lu, H.; Sheng, S.; Lee, M.J.; Ho, C.T.; Yang, C.S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol., 2002, 15, 1042-1050.
49. Spencer, J. P.; Schroeter, H.; Rice-Evans, C. Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochemistry, 2001, 354, 493-500.
50. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Methylation of tea catechins by rat liver homogenates. Biosci. Biotechnol. Biochem., 1999, 63, 430-432.
51. Zhu, B.T.; Patel, U.K.; Cai, M.X.; Conney, A.H. O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-omethyltransferase. Drug Metab. Dispos., 2000, 28, 1024-1030.
52. Lu, H.; Meng, X.; Yang, C.S. Enzymology of methylation of tea catechins and inhibition of catechol-o-methyltransferase by (-)- epigallocatechin gallate. Drug Metab. Dispos., 2003, 31, 572-579.
53. Chen, D.; Wang, C. Y.; Lambert, J. D.; Ai, N.; Welsh, W. J.; Yang, C. S. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem. Pharmacol., 2005, 69, 1523-1531.
54. Fang, M.Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res., 2003, 63, 7563-7570.
55. Lambert, J. D.; Rice, J. E.; Hong, J.; Hou, Z.; Yang, C. S. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorg. Med. Chem. Lett., 2005, 15, 873-876.
56. Magdalou, J.; Antoine, B.; Ratanasavanh, D.; Siest, G. Phenobarbital induction of cytochrome p-450 and UDPglucuronosyltransferase in rabbit liver plasma membranes. Enzyme, 1982, 28, 41-47.
57. Spencer, P. E.; Schroeter, H.; Crossthwaithe, A. J.; Kuhnle, G.; Williams, R. J.; Rice-Evans, C. Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxideinduced cell death in neurons and fibroblasts. Free Radic. Biol. Med., 2001, 31, 1139-1146.
58. Little, J.M.; Drake, R.R.; Vonk, R.; Kuipers, F.; Lester, R.; Radominska, A. Characterization of human liver microsomal UDPglycosyltransferases using photoaffinity analogs. J. Pharmacol. Exp. Ther., 1995, 273, 1551-1559.
59. Magdalou, J.; Antoine, B.; Ratanasavanh, D.; Siest, G. Phenobarbital induction of cytochrome p-450 and UDPglucuronosyltransferase in rabbit liver plasma membranes. Enzyme, 1982, 28, 41-47.
60. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos., 1999, 27, 309-316.
61. Xiao, J.; Högger, P. Metabolism of dietary flavonoids in liver microsomes. Curr. Drug Metab., 2013, 14, 381-391.
62. Sang, S.; Yang, C.S. Structural identification of novel glucoside and glucuronide metabolites of (-)-epigallocatechin-3-gallate in mouse urine using liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom., 2008, 22, 3693-3699.
63. Crespy, V.; Nancoz, N.; Oliveira, M.; Hau, J.; Courtet-Compondu, M.C.; Williamson, G. Glucuronidation of the green tea catechins (-)-epigallocatechin- 3-gallate and (-)-epicatechin-3-gallate, by rat hepatic and intestinal microsomes. Free Radic. Res., 2004, 38, 1025-1031.
64. Moon, Y.H.; Lee, J.H.; Ahn, J.S.; Nam, S.H.; Oh, D.K.; Park, D.H.; Chung, H.J.; Kang, S.; Day, D.F.; Kim, D. Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from leuconostoc mesenteroides B-1299CB. J. Agric. Food Chem., 2006, 54, 1230-1237.
65. Gessner, T.; Jacknowitz, A.; Vollmer; C.A. Studies of mammalian glucoside conjugation. Biochem. J., 1973, 132, 249-258.
66. Lu, H.; Meng, X.; Li, C.; Sang, S.; Patten, C.; Sheng, S.; Hong, J.; Bai, N.; Winnik, B.; Ho, C. T.; Yang, C. S. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab. Dispos., 2003, 31, 452-461.
67. Zhang, Y.; Hendrich, S.; Murphy, P.A. Glucuronides are the main isoflavone metabolites in women. J. Nutr., 2003, 133, 399-404.
68. Runge-Morris, M.; Kocarek, T.A.; Falany, C.N. Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab. Rev., 2013, 45, 15-33.
69. Lu, H. Mechanistic studies on the phase II metabolism and absorption of tea catechins. Toxicology. Ph.D., New Brunswick, Rutgers, The State University of New Jersey; 2002
70. Lambert, J.D.; Sang, S.; Yang, C.S. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharmaceut., 2007, 4, 819-825.
71. Vaidyanathan, J.B.; Walle, T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab. Dispos., 2002,30, 897-903.
72. Sang, S.M.; Lambert, J.D.; Hong, J.; Tian, S.Y.; Lee, M.J.; Stark, R.E.; Ho, C.T.; Yang, C.S. Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice. Chem. Res. Toxicol., 2005, 18, 1762-1769.
73. Moridani, M.Y.; Scobie, H.; Salehi, P.; O'Brien, P.J. Catechin metabolism: glutathione conjugate formation catalyzed by tyrosinase, peroxidase, and cytochrome p450. Chem. Res. Toxicol., 2001, 14, 841-848.
74. Lambert, J.D.; Sang, S.; Hong, J.; Yang, C.S. Anticancer and antiinflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate. J. Agric. Food Chem., 2010, 58, 10016-10019.
75. Sang, S.; Yang, I.; Buckley, B.; Ho, C.T.; Yang, C.S. Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping. Free Radic. Biol. Med., 2007, 43, 362-371.
76. Wang, L. Q.; Meselhy, M. R.; Li, Y.; Nakamura, N.; Min, B. S.; Qin, G. W.; Hattori, M. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem. Pharm. Bull., 2001, 49, 1640-1643.
77. Schantz, M.; Erk, T.; Richling, E. Metabolism of green tea catechins by the human small intestine. Biotechnol. J., 2010, 5, 1050-1059.
78. Meng, X.; Sang, S.; Zhu, N.; Lu, H.; Sheng, S.; Lee, M.; Ho, C.; Yang, C. S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol., 2002, 15, 1042-1050.
79. Meselhy, M.R.; Nakamura, N.; Hattori, M. Biotransformation of (-)-epicatechin 3-o-gallate by human intestinal bacteria. Chem. Pharm. Bull., 1997, 45, 888-893.
80. Akiko Takagaki, Fumio Nanjo. Catabolism of (+)-Catechin and (-)-Epicatechin by Rat Intestinal Microbiota. J. Agric. Food Chem., 2013, 61, 4927-4935.
81. Chen, H.D.; Hayek, S.; Guzman, J.R.; Gillitt, N.D.; Ibrahim, S.A.; Jobin, C.; Sang, S.M. The microbiota is essential for the generation of black tea theaflavins-derived metabolites. PLoS One, 2012, 7, e51001.